Lepota Inc. (LEPX) financial statements (2021 and earlier)

Company profile

Business Address 5348 VEGAS DR.
LAS VEGAS, NV 89108
State of Incorp. NV
Fiscal Year End July 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments02184
Cash and cash equivalents02184
Deferred costs  6  
Disposal group, including discontinued operation12   
Other undisclosed current assets(1)(2)(6)  
Total current assets:02184
Noncurrent Assets
Other undisclosed noncurrent assets 2   
Total noncurrent assets: 2   
TOTAL ASSETS:05184
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities447  
Accrued liabilities  3  
Employee-related liabilities444  
Debt1155  
Other undisclosed current liabilities (7)   
Total current liabilities:15212  
Noncurrent Liabilities
Long-term debt and lease obligation   56
Long-term debt, excluding current maturities   56
Liabilities, other than long-term debt   46
Deferred revenue and credits 2
Due to related parties   44
Other undisclosed noncurrent liabilities(30)7(23)  
Total noncurrent liabilities:(30)7(23)1012
Total liabilities:(15)10(11)1012
Stockholders' equity
Stockholders' equity attributable to parent, including:(15)(7)(11)(2)(7)
Common stock   65
Additional paid in capital22221093
Accumulated deficit(44)(37)(27)(17)(15)
Receivable from shareholders or affiliates for issuance of capital stock    1
Other undisclosed stockholders' equity attributable to parent776  
Other undisclosed stockholders' equity30(9)23 (1)
Total stockholders' equity:15(17)12(2)(8)
TOTAL LIABILITIES AND EQUITY:0(7)184

Income statement (P&L) ($ in thousands)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
Revenue, net64
Gross profit:   64
Operating expenses(15)(10)(10)(7)(6)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
    (6)
Other undisclosed operating income    6
Operating loss:(15)(10)(20)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(15)(10)(20)(1)(1)
Loss from equity method investments  (10)  
Loss from continuing operations:(15)(10)(30)(1)(1)
Loss from discontinued operations(12)(10)(10)  
Other undisclosed loss before gain (loss) on sale of properties(10)    
Loss before gain (loss) on sale of properties:(37)(20)(40)(1)(1)
Other undisclosed net income1910   
Net loss:(17)(10)(40)(1)(1)
Other undisclosed net income attributable to parent3    
Net loss available to common stockholders, diluted:(15)(10)(40)(1)(1)

Comprehensive Income ($ in thousands)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
Net loss:(17)(10)(40)(1)(1)
Comprehensive loss, net of tax, attributable to parent:(17)(10)(40)(1)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: